Fayyad Abdalla M, Harrington Kevin F
Early Hum Dev. 2005 Nov;81(11):865-76. doi: 10.1016/j.earlhumdev.2005.09.005. Epub 2005 Nov 11.
Preeclampsia, being one of the leading causes of maternal and perinatal morbidity and mortality, has been the subject of extensive research since its description. Preeclampsia has been called the disease of theories due to the enigma surrounding its exact pathophysiology. Despite the absence of treatment that reverses the disease process once started, screening for preeclampsia and intrauterine growth restriction (IUGR) has been a major clinical and research issue since the disease was first reported. This review evaluates the current evidence for prediction and prevention of preeclampsia and IUGR using clinical tests, maternal serum markers, and uterine artery Doppler screening. In addition, we critically evaluate the evidence regarding the different therapeutic strategies for the prevention of preeclampsia and IUGR and the latest clinical recommendations for their use.
子痫前期是孕产妇和围产儿发病及死亡的主要原因之一,自其被描述以来一直是广泛研究的主题。由于围绕其确切病理生理学的谜团,子痫前期被称为理论之病。尽管一旦疾病开始就没有能逆转疾病进程的治疗方法,但自该疾病首次被报道以来,子痫前期和胎儿宫内生长受限(IUGR)的筛查一直是一个主要的临床和研究问题。本综述评估了使用临床检查、母体血清标志物和子宫动脉多普勒筛查来预测和预防子痫前期及IUGR的现有证据。此外,我们严格评估了有关预防子痫前期和IUGR的不同治疗策略的证据以及其使用的最新临床建议。